2 June 2025 in Pirogov Russian Journal of Surgery
Objective. To analyze the first thousand of anatomical resections at the Herzen Moscow Oncology Research Institute between 2009 and 2023. Material and methods. A retrospective study included 1078 patients who underwent thoracoscopic anatomical lung resection: lobectomy (TL — group 1) or segmentectomy (TS — group 2) between 2009 and 2023. Perioperative parameters including gender, age, side of surgery, resected lobe, histological data, surgery time, blood loss, tumor size, duration of pleural drainage were assessed. Postoperative complications were classified according to the TM&M system. Statistical analysis was performed using the Student’s t, Mann—Whitney U and Pearson’s χ2 tests. Results. There were 513 men (47.59%) and 565 women (52.41%). The median age was 61.3 and 59.7 years in both groups, respectively (p=0.672). Lung cancer patients predominated (70.6% and 43.5%, respectively). Stage I of disease was diagnosed in 70.36% of patients. Lymph nodes were affected in 160 patients (14.84%), including 100 (62.5%) ones with N1 and 60 (37.5%) ones with N2. TL was performed in 92% of N1 cases and 91.67% of N2 cases. The overall complication rate was 10.76% (n=116). Complications were less common after TS compared to TL (p=0.007). The conversion rate decreased from 35% in the first years to 1.8% over 10 years. In 2023, this parameter slightly increased to 6.3%. Conclusion. Successful development of thoracoscopic anatomical lung resection program is based on standardization of technique and interchangeability of surgical team. This shortens the learning curve, increases safety of surgeries and reduces conversion rate.
15 June 2026 in Pirogov Russian Journal of Surgery
Objective. To study the immediate and long-term outcomes of segmentectomy and lobectomy for malignant lung tumors. Material and methods. A retrospective study included patients with primary malignant lung tumors who underwent anatomical lung resection, including segmentectomy (335 patients) and lobectomy (1.238 patients) via thoracoscopic and open approaches between January 01, 2009 and December 31, 2022. Patients who required conversion to thoracotomy were included in the open surgery group. We enrolled 240 patients for analysis (120 after segmentectomy for non-small cell lung cancer (NSCLC) and 120 after lobectomy for NSCLC, ratio 1:1). Results. The total number of complications in thoracoscopic segmentectomies differed from lobectomy (4.2% and 9%, respectively; p=0.047). The same trend was observed for open segmentectomies and lobectomies (4.8% and 9.6%, respectively; p=0.05). Recovery of external respiratory function occurred significantly faster after thoracoscopic segmentectomies compared to thoracoscopic lobectomies. Thus, preoperative forced expiratory volumes in 1 second (FEV1) were 85% (42–120) and 89% (80–97), respectively. After 6 months and 1 year, FEV1 after thoracoscopic segmentectomy reached 80% (40–111) and 84% (42–116), after thoracoscopic lobectomy — 80% (70–90) and 82% (72–94), respectively. The same trend was observed in groups of open segmentectomy and lobectomies. Preoperative FEV1 was 79% (39–125) and 90% (43–136), after 6 months — 75% (36–117) and 82% (36–121), after 1 year — 78% (37–123) and 83% (39–130), respectively. The overall 5-year survival rates for patients with stage Ia1 and Ia2 NSCLC after thoracoscopic segmentectomy and lobectomy were 90.4% and 91.5% (p=0.940), 5-year disease-free survival rates — 83.3% and 89.4%, respectively (p=0.949). The overall 5-year survival rates for patients with stage Ia1 and Ia2 NSCLC after open segmentectomy and lobectomy were 79.7% and 83.5% (p=0.951), 5-year disease-free survival rates — 74.5% and 76.9%, respectively (p=0.457). Conclusion. Segmentectomy is associated with lower complication rate than lobectomy, and long-term outcomes are comparable to those of lobectomy in patients with NSCLC <2 cm.
27 February 2026 in Russian Journal of Thoracic and Cardiovascular Surgery
23 April 2024 in P.A. Herzen Journal of Oncology
The review of modern medical literature demonstrates the steadily increasing interest of researchers in anatomical lung segmentectomies. The main question, which has remained relevant for decades, is the oncological feasibility of anatomical segmental resection. The overwhelming number of studies indicate to the validity of this volume of surgery in radical surgical treatment of patients with stage IA1 and IA2 non-small cell lung cancer, i.e., when the tumor size is less than 2 cm without regional metastases. Nevertheless, the discussion remains open. We present a clinical case of long-term recurrence-free follow-up of a patient after anatomical resection of segments I — III of the upper lobe of the left lung for cancer.
23 April 2024 in P.A. Herzen Journal of Oncology
Lung cancer is one of the leading causes of cancer-related mortality worldwide. For a long period of time, lobectomy was considered the minimum surgical treatment for patients with non-small cell lung cancer (NSCLC). Minimising the surgical volume for primary lung tumour has been debated for over 25 years. Anatomic segmental lung resection preserves more lung tissue volume than lobectomy. The effect of anatomic segmental lung resection on long-term survival remains controversial.
16 November 2024 in Siberian journal of oncology
Background. Epithelioid hemangioendothelioma (EHE) is a malignant vascular tumor of mesenchymal origin. In the mediastinum, EHE originates from the large venous vessels of the superior vena cava.The purpose of the study was to describe a rare clinical case of EHE of the unpaired vein and analyze literature data to improve diagnosis and treatment of this disease.Case presentation. We present a rare case of EHE of the unpaired vein in a 23-year-old male patient who admitted to the Herzen Moscow Oncology Research Institute with a posterior mediastinal tumor detected in August 2022. It was known from the medical history that the patient had undergone diagnostic right-sided thoracotomy and tumor biopsy at the place of residence. Morphologically, the tumor was an epithelioid hemangioendothelioma. The histological re-assessment of biopsy specimens at the Herzen Moscow Oncology Research Institute confrmed the diagnosis of EHE. Computed tomography of the chest organs revealed a mass in the posterior mediastinum (in the projection of the lumen of the unpaired vein), measuring 16×14×41 mm, with relatively clear even contours, close to the posterior wall of the trachea at the bifurcation level, the posterior wall of the right main bronchus, the left semicircle of the esophagus (without signs of invasion). Based on the data on the presence of a vascular tumor in the posterior mediastinum on the right, a multidisciplinary medical consilium recommended surgical treatment: right thoracotomy, removal of a posterior mediastinal tumor with resection of the azygos vein, marginal resection of the superior vena cava, and thrombectomy from its lumen. The duration of surgery was 180 minutes, blood loss was 200 ml. Morphological examination confrmed EHE of the unpaired vein. No complications were observed in the postoperative period. The patient was discharged from the hospital on the 8th day after surgery in a satisfactory condition.Conclusion. EHE of the unpaired vein is an extremely rare vascular tumor. The clinical feature of EHE of the unpaired vein is the absence of any pathognomonic signs, which complicates differential diagnosis of mediastinal tumors. Surgery is currently the optimal treatment approach.